Lucie Nekvindová

Institute of Biostatistics and Analyses, Ltd.

Czech Republic

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (7)

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Marek Niedoszytko

MD PhD Prof

Medical University of Gdansk

POLAND

View details

Jakub Závada

Institute of Rheumatology

CZECH REPUBLIC

View details

Mattias Mattsson

SWEDEN

View details

Magdalena Lange

Profesor dr hab.

Gdański Uniwersytet Medyczny

POLAND

View details

Jiri Vencovsky

Institute of Rheumatology

CZECH REPUBLIC

View details

David Starostka

Univerzita Palackého v Olomouci

CZECH REPUBLIC

View details

Herman Mann

Charles University Faculty of Medicine

CZECH REPUBLIC

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lucie Nekvindová

Research Interests

Contact this professor

Articles (7)

Delayed treatment with a tumor necrosis factor alpha blocker associated with worse outcomes in patients with spondyloarthritis: data from the Czech National Registry ATTRA

Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration

Real‐world 6 and 12‐month Drug Retention, Remission and Response Rates of Secukinumab in 2,017 Psoriatic Arthritis patients in 13 European Countries

Switching first-line targeted therapy after not reaching low disease activity within 6 months is superior to conservative approach: a propensity score-matched analysis from the ATTRA registry

Real‐world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: The GO‐CLLEAR Study by the Czech CLL Study Group

Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification

Short-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry

Collaborators (7)

Marek Niedoszytko

Jakub Závada

Mattias Mattsson

Magdalena Lange

Jiri Vencovsky

David Starostka

Herman Mann

Make your next move.